These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25597344)

  • 61. An improved autoanalyzer technique for the determination of serum alkaline phosphatase.
    Price CP; Woodman DD
    Clin Chim Acta; 1971 Dec; 35(2):265-71. PubMed ID: 5125312
    [No Abstract]   [Full Text] [Related]  

  • 62. Human serum glucose-6-phosphatase activity: confirmation of its presence and lack of diagnostic value.
    Belfield A; Goldberg DM
    Clin Chim Acta; 1971 Jan; 31(1):81-5. PubMed ID: 5544064
    [No Abstract]   [Full Text] [Related]  

  • 63. Towards the revival of alkaline phosphatase for the management of bone disease, mortality and hip fractures.
    Lau WL; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2014 Aug; 29(8):1450-2. PubMed ID: 24737443
    [No Abstract]   [Full Text] [Related]  

  • 64. Serum Fractalkines and Cardiovascular Outcomes in the CRIC Study Cohort.
    Yang P; Xu G
    Am J Kidney Dis; 2016 Feb; 67(2):342. PubMed ID: 26802332
    [No Abstract]   [Full Text] [Related]  

  • 65. In Reply to 'Serum Fractalkines and Cardiovascular Outcomes in the CRIC Study Cohort'.
    Shah R
    Am J Kidney Dis; 2016 Feb; 67(2):342. PubMed ID: 26802331
    [No Abstract]   [Full Text] [Related]  

  • 66. Chronic kidney disease, mineral bone disease and future risk of peripheral artery disease: Do associations rule?
    Hecking M; Höbaus C; Schernthaner GH
    Atherosclerosis; 2017 Dec; 267():153-155. PubMed ID: 29126548
    [No Abstract]   [Full Text] [Related]  

  • 67. The story of growth differentiation factor 15: another piece of the puzzle.
    Lindahl B
    Clin Chem; 2013 Nov; 59(11):1550-2. PubMed ID: 24003064
    [No Abstract]   [Full Text] [Related]  

  • 68. Parathyroid hormone--a new prognostic marker of mortality?
    Wüster C
    Eur J Clin Invest; 1997 Dec; 27(12):982-3. PubMed ID: 9466124
    [No Abstract]   [Full Text] [Related]  

  • 69. Ischemia modified albumin in cardiovascular disease.
    Balta S; Alemdar R; Erdogan S; Demir M; Ozturk C; Celik T
    Am J Emerg Med; 2016 Aug; 34(8):1699. PubMed ID: 27236854
    [No Abstract]   [Full Text] [Related]  

  • 70. Biomarkers in cardiovascular medicine: the shame of publication bias.
    Nissen SE
    JAMA Intern Med; 2013 Apr; 173(8):671-2. PubMed ID: 23529374
    [No Abstract]   [Full Text] [Related]  

  • 71. Conclusions and future directions: 'The known unknowns ….'.
    Duncan EL
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():70-71. PubMed ID: 28429553
    [No Abstract]   [Full Text] [Related]  

  • 72. Prognostic value of preoperative serum alkaline phosphatase for predicting 3-year mortality in patients undergoing kidney transplantation: A retrospective study.
    Yoon HJ; Ko DE; Nam SB; Song Y; Yun BH; Ham SY
    PLoS One; 2022; 17(8):e0273662. PubMed ID: 36037177
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease.
    Haarhaus M; Cianciolo G; Barbuto S; La Manna G; Gasperoni L; Tripepi G; Plebani M; Fusaro M; Magnusson P
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631265
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease.
    Ureña-Torres PA; Vervloet M; Mazzaferro S; Oury F; Brandenburg V; Bover J; Cavalier E; Cohen-Solal M; Covic A; Drüeke TB; Hindié E; Evenepoel P; Frazão J; Goldsmith D; Kazama JJ; Cozzolino M; Massy ZA;
    Clin Kidney J; 2019 Apr; 12(2):269-280. PubMed ID: 30976408
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.
    Soohoo M; Feng M; Obi Y; Streja E; Rhee CM; Lau WL; Wang J; Ravel VA; Brunelli S; Kovesdy CP; Kalantar-Zadeh K
    Am J Nephrol; 2016; 43(2):85-96. PubMed ID: 26950688
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
    Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
    PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease?
    Lau WL; Kalantar-Zadeh K; Kovesdy CP; Mehrotra R
    Hemodial Int; 2014 Oct; 18(4):720-4. PubMed ID: 25597344
    [No Abstract]   [Full Text] [Related]  

  • 78. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients.
    Couttenye MM; D'Haese PC; Van Hoof VO; Lemoniatou E; Goodman W; Verpooten GA; De Broe ME
    Nephrol Dial Transplant; 1996 Jun; 11(6):1065-72. PubMed ID: 8671970
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?].
    Jean G; Souberbielle JC; Granjon S; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Chazot C
    Nephrol Ther; 2013 Jun; 9(3):154-9. PubMed ID: 23545236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.